‘Landmark’ Pancreatic Cancer Drug Keeps Patients Alive for Twice as Long
13 Articles
13 Articles
A New Pill Finally Offers Hope for Pancreatic Cancer
A medical breakthrough is doubling the survival time for patients with one of the most aggressive forms of cancer. A new pill taken daily to treat pancreatic cancer has shown positive results in a study with 500 patients. Scientists found the drug reduced the risk of death by 60% compared with chemotherapy. Dr. Mark Goldsmith, CEO of the biotech company that funded the study, joins the show.
Allsup Highlights Pancreatic Cancer Research And Importance Of Timely SSDI Applications
Belleville, Illinois, June 04, 2026 (GLOBE NEWSWIRE) -- Allsup, a leading provider of Social Security Disability Insurance (SSDI) representation, return to work and veterans disability appeals services, is highlighting new pancreatic cancer research shared at the 2026 American Society of Clinical Oncology (ASCO) annual meeting. Allsup urges people who can no longer work because of a serious illness to apply for SSDI as soon as possible. Waiting …
Dnevni list Danas
nin.rsThe effectiveness of the new drug daracsonrasib encourages scientists that the treatment of one of the deadliest types of cancer could be improved.
The new drug Daraxonrasib could double the survival time of pancreatic cancer – but it does not cure the cancer. Successful therapy is only possible with early diagnosis.
It's not every day that a medical conference elicits such a standing ovation, but that's exactly what happened a few days ago when an entire hall of doctors and cancer experts rose to their feet to applaud a slide showing that the drug daraxonrasib doubled the survival time for pancreatic cancer patients. This reaction reflects the immense excitement surrounding this breakthrough in treating one of the most challenging forms of cancer. But the d…
A Daily Pill, A Big Shift: Inside New Pancreatic Cancer Survival Breakthrough
Pancreatic cancer has always carried a kind of weight that no one really wants to put into words. It’s one of those diagnoses that usually comes in late, moves fast, and leaves very little room for options. Unlike some other cancers where early detection can completely change the outcome, this one often stays quiet until it has already spread. That’s part of the reason it has stayed so deadly for so long, and why even small improvements in treat…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
